Port Access Kit
- Designed to standardize port access procedures
- Provides the convenience of necessary kit components in a common package
- Kit components are organized to facilitate sterile "best practices" for port access related procedures
- Assists clinicians in complying with guidelines for sterile port access outlined by nursing societies and the CDC
- Procedural Checklist included in every kit:
- Educate and assist in sterile port access technique
- Convenient documentation and tracking of port access procedure
- Procedural checklist for simplified protocol documentation
Features
An estimated 3-6% of ports placed will develop a port-related infection, impacting a cancer patient’s already challenging treatment.1, 2, 3, 4, 5 Port-related infections may be due to the initial access or in-dwell of an infusion set in the patient’s port.
Port Access Related Implications
For the patient:
- Port removal
- Chemotherapy/treatment interruption
- Hospital in-patient stay
- Secondary complications from infection
- Placement of a 2nd device that may not offer the benefits of a port
For the facility:
- Port removal
- Potential hospital stay
- Additional procedures and devices
- Less or lack of reimbursement due to recent CMS changes regarding central line infections
Proper Port-Access Technique Matters
Nearly 80% of Oncology Nurses surveyed by Bard cite poor sterile technique, site prep or access procedures as the likely cause for port access related infections.†
Help clinicians to meet the following:
Centers for Disease Control (CDC) Guidelines
Infusion Nursing Society (INS) Standards of Practice
Oncology Nursing Society (ONS) Guidelines
Occupational Safety & Health Administration (OSHA) Guidelines
The Joint Commission (JCAHO) National Patient Safety GoalsBard® Port Access Kit available in the following safety infusion set configurations:
- Vescia, S. et al., Management of Venous Port Systems in Oncology: A review of current evidence, Annals of Oncology, Sept 2007, 19:9-15.
- Groeger, Jeffrey S. et.al., Infectious Morbidity Associated with Long-Term Use of Venouos Access Devices in Patients with Cancer, Annals of Internal Medicine, 1993; 119:1168-1174.
- Grannan, Kevin I., et.al., Early and Late Complications of Totally Implantable Venous Access Devices, Journal of Surgical Oncology, 1990, 44:52-54.
- Pegeus, David, et.al., Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients, Journal of Surgical Oncology, 49: 156-162 (1992).
- Groeger, Jeffrey S. et.al., Venous Access in the Cancer Patient, Principles and Practice of Oncology, 1991; vol. 5 no. 3
† Survey results on file at C. R. Bard, Inc.
Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.
Specifications
| PowerLoc® MAX PAK | Gauge | Inch | With Y-Site Product Code | Without Y-Site Product Code |
|---|---|---|---|---|
| | 19 | .75" | 2131975 | 2141975 |
| 1" | 2131910 | 2141910 | ||
| 1.5" | 2131915 | 2141915 | ||
| 20 | .75" | 2132075 | 2142075 | |
| 1" | 2132010 | 2142010 | ||
| 1.5" | 2132015 | 2142015 | ||
| 22 | .75" | 2132275 | 2142275 | |
| 1" | 2132210 | 2142210 | ||
| 1.5" | 2132215 | 2142215 |
| PowerLoc® PAK | Gauge | Inch | With Y-Site Product Code | Without Y-Site Product Code |
|---|---|---|---|---|
| | 19 | .75" | 2671934 | 2651934 |
| 1" | 2671910 | 2651910 | ||
| 1.5" | 2671915 | 2651915 | ||
| 20 | .75" | 2672034 | 2652034 | |
| 1" | 2672010 | 2652010 | ||
| 1.5" | 2672015 | 2652015 | ||
| 22 | .75" | 2672234 | 2652234 | |
| 1" | 2672210 | 2652210 | ||
| 1.5" | 2672215 | 2652215 |
| MiniLoc® PAK | Gauge | Inch | With Y-Site Product Code | Without Y-Site Product Code |
|---|---|---|---|---|
| | 19 | .75" | 2681934 | 2631934 |
| 1" | 2681910 | 2631910 | ||
| 1.5" | 2681915 | 2631915 | ||
| 20 | .75" | 2682034 | 2632034 | |
| 1" | 2682010 | 2632010 | ||
| 1.5" | 2682015 | 2632015 | ||
| 22 | .75" | 2682234 | 2632234 | |
| 1" | 2682210 | 2632210 | ||
| 1.5" | 2682215 | 2632215 |
| SafeStep® PAK | Gauge | Inch | With Y-Site Product Code | Without Y-Site Product Code |
|---|---|---|---|---|
| | 19 | .75" | PA-0033YN | PA-0033 |
| 1" | PA-0034YN | PA-0034 | ||
| 1.5" | PA-0040YN | PA-0040 | ||
| 20 | .75" | PA-0031YN | PA-0031 | |
| 1" | PA-0032YN | PA-0032 | ||
| 1.5" | PA-0038YN | PA-0038 | ||
| 22 | .75" | PA-0029YN | PA-0029 | |
| 1" | PA-0030YN | PA-0030 | ||
| 1.5" | PA-0036YN | PA-0036 |
Kit Components
| Description | Kit |
|---|---|
| Your Preferred Bard® Huber Needle | 1 |
| Syringe, Sodium Chloride (Saline) 0.9%, 10mL | 1 |
| Chloraprep™ One-Step Applicator | 1 |
| Dressing, Transparent | 1 |
| Gauze Pad, 2 in. x 2 in. | 4 |
| Gloves, Non-Latex, Sterile | 2 |
| Procedure Checklist | 1 |
| Mask | 1 |
| Prep Pad, Alcohol | 1 |
| Prep Pad, Skin Protectant | 1 |
| Tape Strips, Anchor (3 per) | 1 |
| Towel, Absorbent | 1 |
| Dressing Change Label | 1 |
Literature
Please refer below to the Instructions for Use (IFUs) for any indications, contraindications, hazards, warnings, and cautions.
